Family Office of America, Inc. (FOFA): Shareholders' Equity
$664.5K
As of 2025-12-31
$997.2K
As of 2026-06-30
+43.7%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $664.5K | n/m | 2026-04-16, Balance as of period end |
| 2024-12-31 | -$23.4K | n/m | 2026-04-16, Balance as of period end |
| 2023-12-31 | -$523.0K | n/m | 2025-03-10, Balance as of period end |
| 2022-12-31 | $224.0K | -70.9% | 2024-07-18, Balance as of period end |
| 2021-12-31 | $770.4K | n/a | 2023-04-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Family Office of America, Inc. (FOFA) | 2025-12-31 | $664.5K | n/m |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $2.32M | -46.3% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $80.66M | -29.8% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $20.63M | -61.7% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.06M | -67.2% |
| Vivos Inc (RDGL) | 2025-12-31 | $1.66M | -22.7% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $7.05M | -40.0% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $2.93M | -24.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $5.42M | +21.1% |
Compare FOFA, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗